A direct fluorescence assay for quantitative analysis of ornithine decarboxylase activity and inhibitor screening
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2026.111468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Jae-Yeon Choi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Infectious Diseases, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Ornithine Decarboxylase, Ornithine Decarboxylase Inhibitors, Enzyme Assays, Enzyme Inhibitors. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Ornithine decarboxylase (ODC) catalyzes the first committed step in polyamine biosynthesis and plays a central role in cellular growth and proliferation. Quantitative analysis of ODC activity has traditionally relied on radiometric or coupled-enzyme assays, which limit scalability and accessibility. Here, we report on the development of 1,2-diacetylbenzene (DAB)-ODC, a fluorescence-based assay that enables direct, sensitive, and high-throughput quantification of ODC activity by detecting putrescine through its reaction with DAB. Using purified recombinant ODC from Saccharomyces cerevisiae and humans, we show that DAB-ODC supports measurement of enzyme activity and accurate determination of steady-state kinetic parameters. Inhibition studies with the inhibitor DL-α-difluoromethylornithine and three recently reported DL-α-difluoromethylornithine analogs yielded IC50 values consistent with those obtained using established orthogonal assays. All enzymatic measurements were validated by thin-layer chromatography. Assay performance metrics, including CV, Z' factor, and signal-to-background ratios, demonstrate compatibility with large-scale chemical screening. Together, these results establish DAB-ODC as a versatile platform for ODC enzymology, inhibitor profiling, and high-throughput interrogation of polyamine metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Section of Infectious Diseases, New Haven, Connecticut, USA.
- Małopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.
- Department of Chemistry, University of California, Irvine, California, USA.
- Department of Chemistry, University of California, Irvine, California, USA; Department of Pharmaceutical Sciences, University of California, Irvine, California, USA.
- Department of Internal Medicine, Section of Infectious Diseases, New Haven, Connecticut, USA; Department of Microbial Pathogenesis, New Haven, Connecticut, USA; Department of Pathology, Yale School of Medicine, New Have…
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
- Foundation for Polish Science
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Choi, J. Y., Bereta, G., Furry, M., Vanderwal, C. D., Grudnik, P., & Ben Mamoun, C. (2026). A direct fluorescence assay for quantitative analysis of ornithine decarboxylase activity and inhibitor screening. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.111468
Vancouver
Choi JY, Bereta G, Furry M, Vanderwal CD, Grudnik P, Ben Mamoun C. A direct fluorescence assay for quantitative analysis of ornithine decarboxylase activity and inhibitor screening. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.111468
BibTeX
@article{Choi2026,
author = {Choi, Jae-Yeon and Bereta, Grzegorz and Furry, Matthew and Vanderwal, Christopher D and Grudnik, Przemysław and Ben Mamoun, Choukri},
title = {A direct fluorescence assay for quantitative analysis of ornithine decarboxylase activity and inhibitor screening},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2026.111468}
}
EUVIMED